Commodore Capital’s Attovia Therapeutics ATTO Stock Holding History
Bought
Maintained
Sold
Other funds holding ATTO
Commodore Capital's ATTO Position: Q3 2026 in Review
Commodore Capital opened a new position in Attovia Therapeutics (ATTO) in Q3 2026: 1,160,000 shares worth $19.9M. The stake represents 1.54% of the portfolio and ranks #20 among its holdings.
57 funds tracked by Wall St. Rank hold ATTO as of Q3 2026.
- Commodore Capital held 1,160,000 shares of Attovia Therapeutics worth $19.9M as of Q3 2026.
- Attovia Therapeutics was a new Commodore Capital position in Q3 2026.
- Attovia Therapeutics made up 1.54% of Commodore Capital's portfolio in Q3 2026, its #20 holding.
- 57 funds tracked by Wall St. Rank held Attovia Therapeutics as of Q3 2026.
Based on Commodore Capital's 13F filing for Q3 2026, filed 16 Nov 2026.